Gregory I. Frost
2012
In 2012, Gregory I. Frost earned a total compensation of $2.3M as Former President and Chief Executive Officer at Halozyme Therapeutics, a 235% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $57,258 |
---|---|
Option Awards | $382,248 |
Salary | $424,130 |
Stock Awards | $1,423,274 |
Other | $5,219 |
Total | $2,292,129 |
Frost received $1.4M in stock awards, accounting for 62% of the total pay in 2012.
Frost also received $57.3K in non-equity incentive plan, $382.2K in option awards, $424.1K in salary and $5.2K in other compensation.
Rankings
In 2012, Gregory I. Frost's compensation ranked 3,106th out of 11,487 executives tracked by ExecPay. In other words, Frost earned more than 73.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,106 | 73rd |
Manufacturing | 1,083 | 75th |
Chemicals And Allied Products | 243 | 80th |
Drugs | 143 | 85th |
Biological Products, Except Diagnostic Substances | 25 | 84th |
Frost's colleagues
We found five more compensation records of executives who worked with Gregory I. Frost at Halozyme Therapeutics in 2012.
2012
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2012
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2012
James Shaffer
Halozyme Therapeutics
Former Vice President and Chief Commercial Officer
2012
Jean Liu
Halozyme Therapeutics
General Counsel
2012
David Ramsay
Halozyme Therapeutics